Congestive heart failure: What can we offer our patients?

CMAJ. Canadian Medical Association Journal

Volumn 165, Issue 8, 2001, Pages 1053-1055

  Kostuk, W J ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; LOSARTAN; SPIRONOLACTONE; TUMOR NECROSIS FACTOR; VALSARTAN;

AIRWAY PRESSURE; ASSISTED CIRCULATION; CANADA; CARDIOMYOPATHY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE COURSE; EXERCISE TOLERANCE; HEALTH CARE COST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; INCIDENCE; ISCHEMIC HEART DISEASE; MORALITY; NOTE; QUALITY OF LIFE; RISK FACTOR; VALVULAR HEART DISEASE;

EID: 0034794007     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (22)

1. Changing trends in mortality and admissions to hospital for elderly patients with congestive heart failure in Montreal
2. Diagnosis and management of heart failure
3. Defining diastolic heart failure. A call for standardized diagnostic criteria
4. How many medicines do patients with heart failure need?
5. Randomized, controlled trial of long term moderate exercise training in chronic heart failure: Effects on functional capacity, quality of life and clinical outcome
6. The effect of digoxin on mortality and morbidity in patients with heart failure
7. The effect of spironolactone on morbidity and morality in patients with severe heart failure. Randomized aldactone evaluation study
8. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
9. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
10. Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction
11. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial
12. Comparative effects of low and high doses of the an-giotensin converting enzyme inhibitor, lisinopril, on mortality and morbidity in chronic heart failure
13. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
14. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomized trial - The Losartan Heart Failure Survival Study ELITE II
15. Rationale and design of the valsartan heart failure trial. A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in congestive heart failure
16. Results from the Valsartan in heart failure trial [oral presentation]
17. The effects of carvedilol on morbidity and mortality in patients with chronic heart failure
18. The Cardiac Insufficiency Bisoprolol Study (CIBIS-11): A randomized trial
19. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized interventional trial in congestive heart failure (MERIT-HF)
20. Effect of carvedilol on survival in severe chronic heart failure
21. Team management of patients with heart failure. A statement for health care professionals from the Cardiovascular Nursing Council of the American Heart Association